Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Collplant Holdings Ltd ADR (CQPTY)

Collplant Holdings Ltd ADR (CQPTY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk PR Newswire - Thu Oct 16, 2025

REHOVOT, Israel , Oct. 16, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its...

CQPTY : 9.0000 (+1.69%)
CLGN : 1.4700 (+2.08%)
CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler PR Newswire - Tue Sep 30, 2025

CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trials

CQPTY : 9.0000 (+1.69%)
CLGN : 1.4700 (+2.08%)
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference PR Newswire - Mon Aug 25, 2025

REHOVOT, Israel , Aug. 25, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing disruptive technologies and...

CQPTY : 9.0000 (+1.69%)
CLGN : 1.4700 (+2.08%)
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire - Wed Aug 20, 2025

- Sales of rhCollagen and bioinks primed for augmentation following new U.S.-based commercial executive hire -

CQPTY : 9.0000 (+1.69%)
CLGN : 1.4700 (+2.08%)

Barchart Exclusives

D-Wave Just Got a ‘Formidable’ Quantum Computing ‘Ally.’ Should You Buy QBTS Stock Here? Barchart - 1 hour ago
Is QBTS seen as a high-risk, high-reward bet as an early quantum leader or a core holding for conservative portfolios? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot